| Long-term Follow-Up Study of RGX-314 and Fellow Eye Substudy (NCT03999801) | AbbVie | 2019-05-31 |
| Daratumumab Retreatment in Participants With Multiple Myeloma Who Have Been Previously Treated With Daratumumab (NCT03871829) | Janssen Research & Development, LLC | 2019-05-31 |
| Aromatase Inhibitor Therapy With or Without Fulvestrant for the Treatment of HR Positive Metastatic Breast Cancer With an ERS1 Activating Mutation, the INTERACT Study (NCT04256941) | M.D. Anderson Cancer Center | 2019-05-31 |
| A Study to Evaluate Efficacy and Safety of Perampanel Administered as an Adjunctive Therapy in Pediatric Participants With Childhood Epilepsy (NCT04015141) | Eisai Inc. | 2019-05-31 |
| Ibrutinib and PD-1 Blockade in High Risk Lymphocytic Leukemia (NCT03514017) | H. Lee Moffitt Cancer Center and Research Institute | 2019-05-31 |
| Mirvetuximab Soravtansine (IMGN853) and Bevacizumab in Patients With Endometrial Cancer (NCT03836157) | University of Oklahoma | 2019-05-31 |
| LCZ696 in Advanced LV Hypertrophy and HFpEF (NCT03928158) | National Medical Research Center for Cardiology, Ministry of Health of Russian Federation | 2019-05-31 |
| A Study to Evaluate Dimolegin in Prevention of Thromboembolic Complications During Knee Replacement (NCT05189002) | PharmaDiall Ltd. | 2019-05-31 |
| A Study Comparing Immunopheresis® Alone or In Combination With Chemotherapy Versus Chemotherapy Alone in Treatment of Advanced Breast Cancer Patients (NCT04004910) | Immunicom Inc | 2019-05-31 |
| Compare the Efficacy and Safety of Beta-Glucan as Add-On to Statin in Subjects With Hyperlipidemia. (NCT03857256) | Montreal Heart Institute | 2019-05-31 |
| A Study of KN046 in Subjects With Locally Advanced or Metastatic Triple-negative Breast Cancer (NCT03872791) | Jiangsu Alphamab Biopharmaceuticals Co., Ltd | 2019-05-30 |
| Androgen Deprivation Therapy (ADT) and Pembrolizumab for Advanced Stage Androgen Receptor-positive Salivary Gland Carcinoma (NCT03942653) | Manish Patel | 2019-05-30 |
| Chemotherapy Combined With Apatinib and PD-1 Antibody (NCT05025033) | Tianjin Medical University Cancer Institute and Hospital | 2019-05-30 |
| The Safety and Tolerability of GT0918 in Subjects With mHSPC and mCRPC (NCT03899467) | Suzhou Kintor Pharmaceutical Inc, | 2019-05-30 |
| Low-dose Atropine for the Prevention of Myopia Progression in Danish Children (NCT03911271) | Line Kessel | 2019-05-30 |
| Text Messaging-Based Smoking Cessation Program for Homeless Youth (NCT03874585) | RAND | 2019-05-30 |
| Efficacy and Safety Study of Hemay005 in Subjects With Moderate to Severe Plaque Psoriasis (NCT04102241) | Tianjin Hemay Pharmaceutical Co., Ltd | 2019-05-30 |
| I-131-1095 Radioligand Plus Enzalutamide vs Enzalutamide for mCRPC That Progressed During Abiraterone (ARROW). (NCT03939689) | Progenics Pharmaceuticals, Inc. | 2019-05-30 |
| Exploratory fMRI Study on the Treatment for Impulsive Aggression in Children With ADHD (NCT03638466) | Supernus Pharmaceuticals, Inc. | 2019-05-30 |
| Lentiviral Vector Gene Therapy - The Guard1 Trial of AVR-RD-02 for Subjects With Type 1 Gaucher Disease (NCT04145037) | AVROBIO | 2019-05-30 |
| Clinical Trial to Evaluate the Safety and Tolerability of Hydrogen in Patients With Parkinson's Disease (NCT03971617) | Stony Brook University | 2019-05-29 |
| A Study of Esomeprazole in Children With Autism (NCT03866668) | Stanford University | 2019-05-29 |
| HF2 Therapy in the Treatment of Active Ulcerative Colitis (NCT03720002) | Sheba Medical Center | 2019-05-29 |
| Evaluation of a Combination of a Plant Extract and a Probiotic on Glucidic Metabolism in Women With PCOS and High Insulin Levels (NCT04029805) | Biosearch S.A. | 2019-05-29 |
| A Study to Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Chronic Pruritic Diseases (NCT03858634) | Genentech, Inc. | 2019-05-29 |
| The Use of Hepatitis C Positive Kidneys in Hepatitis C Negative Kidney Transplant Recipients (NCT03809533) | Amit D Tevar, MD | 2019-05-29 |
| Abemaciclib + Nivolumab in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed or Recurred Within Six Months After Platinum-based Chemotherapy (NCT03655444) | Washington University School of Medicine | 2019-05-29 |
| Ramucirumab + Pembrolizumab in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (NCT03650764) | Washington University School of Medicine | 2019-05-29 |
| M6620 and Carboplatin With or Without Docetaxel in Treating Patients With Metastatic Castration-Resistant Prostate Cancer (NCT03517969) | National Cancer Institute (NCI) | 2019-05-29 |
| Anti-epileptogenic Effects of Eslicarbazepine Acetate (NCT06597084) | Bial - Portela C S.A. | 2019-05-29 |
| The Impact of Ashwagandha on Perceived Stress, Sleep and Food Cravings in College Students (NCT05430685) | University of Colorado, Colorado Springs | 2019-05-29 |
| Effisayil™ ON: A Study to Test Long-term Treatment With Spesolimab in People With Generalized Pustular Psoriasis Who Took Part in a Previous Study (NCT03886246) | LEO Pharma | 2019-05-29 |
| A Trial to Study BAY1753011 in Patients With Congestive Heart Failure (NCT03901729) | Bayer | 2019-05-29 |
| DPI-Tobra-Kind Cyclops® in Children With Cystic Fibrosis (NCT03485456) | University Medical Center Groningen | 2019-05-29 |
| Naproxen Sodium/Acetaminophen Proof of Concept Dosing Study (NCT03879408) | Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division | 2019-05-28 |
| Open Label Study of mRNA-3704 in Patients With Isolated Methylmalonic Acidemia (NCT03810690) | ModernaTX, Inc. | 2019-05-28 |
| Safety and Efficacy of Ophthalmic Phentolamine Mesylate in Glaucoma (NCT03960866) | Ocuphire Pharma, Inc. | 2019-05-28 |
| Liquid Biopsy in Monitoring the Neoadjuvant Chemotherapy and Operation in Gastric Cancer (NCT03957564) | Affiliated Hospital of Qinghai University | 2019-05-28 |
| Study to Evaluate the Effect of Filgotinib on Semen Parameters in Adult Males With Active Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, or Non-radiographic Axial Spondyloarthritis (NCT03926195) | Lakefront Biotherapeutics NV | 2019-05-28 |
| Nivolumab Plus Chemoradiotherapy in Patients With Muscle-invasive Bladder Cancer (MIBC) Not Undergoing Cystectomy (NCT03993249) | Hellenic GenitoUrinary Cancer Group | 2019-05-28 |
| A Safety and Efficacy Study of IS-001 Injection in Patients Undergoing Robotic Hysterectomy (NCT03937505) | Intuitive Surgical | 2019-05-28 |
| Trial for the Treatment of Acute Hepatitis C for 8 Weeks With Sofosbuvir/Velpatasvir (NCT03818308) | Hannover Medical School | 2019-05-28 |
| A Study of Efruxifermin in Subjects With Histologically Confirmed Nonalcoholic Steatohepatitis (NASH) (NCT03976401) | Akero Therapeutics, Inc | 2019-05-28 |
| Restoration of Hypoglycemia Awareness With Metoclopramide (NCT03970720) | Simon Fisher | 2019-05-28 |
| Ramucirumab and Pembrolizumab Versus Standard of Care in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Non-Match Treatment Trial) (NCT03971474) | SWOG Cancer Research Network | 2019-05-28 |
| KRN125 for Mobilization of Hematopoietic Stem Cells (NCT03993639) | Kyowa Kirin Co., Ltd. | 2019-05-28 |
| SIKAMIC (SIklos on Kidney Function and AlbuMInuria Clinical Trial) (NCT03806452) | Theravia | 2019-05-28 |
| Radiation and Combination Immunotherapy for Melanoma (NCT03850691) | Masonic Cancer Center, University of Minnesota | 2019-05-28 |
| Riluzole in the Treatment of Spasticity in the Traumatic Chronic Spinal Cord Injury Condition (NCT02859792) | Assistance Publique Hopitaux De Marseille | 2019-05-27 |
| TAHP for Patients With HER2-positive Early Breast Cancer and Subsequent AHP Adjuvant tHerapy After Surgery (NCT03881878) | Samsung Medical Center | 2019-05-27 |
| Concentrate of Autologous Rich Plasma in Growth Factors in the Treatment of the Thin Endometrium (NCT03387501) | Sara Rafael Fernandez | 2019-05-27 |
| Fibroblast Growth Factor (FGFs) / Fibroblast Growth Factor Receptor (FGFRs) Genetic as a Second-line Therapy for Recurrent / Progressive Gastric Cancer With INCB054828 and Paclitaxel a Study to Evaluate the Safety and Efficacy of Combination Therapy. (NCT05529667) | Yonsei University | 2019-05-27 |
| Paclitaxel in Patients With GIST With Low P-glycoprotein Expression After Failure of at Least Imatinib and Sunitinib, and Regorafenib. (NCT03944304) | Asan Medical Center | 2019-05-27 |
| ORIN1001 in Patients with Advanced Solid Tumors and Relapsed Refractory Metastatic Breast Cancer (NCT03950570) | Orinove, Inc. | 2019-05-25 |
| Combination of GT90001 and Nivolumab in Patients With Metastatic Hepatocellular Carcinoma(HCC) (NCT03893695) | Suzhou Kintor Pharmaceutical Inc, | 2019-05-25 |
| Valproic Acid in Combination With Bevacizumab and Oxaliplatin/Fluoropyrimidine Regimens in Patients With Ras-mutated Metastatic Colorectal Cancer (NCT04310176) | National Cancer Institute, Naples | 2019-05-24 |
| Efficacy and Tolerability Study of Two Dosing Regimens of CTP-543 in Adults With Alopecia Areata (NCT03941548) | Concert Pharmaceuticals | 2019-05-24 |
| A Study About Safety and Efficacy of Pirfenidone to Treat Grade 2 or Grade3 Radiation-induced Lung Injury. (NCT03902509) | Beijing Continent Pharmaceutical Co, Ltd. | 2019-05-24 |
| A Trial of Metformin in Individuals With Fragile X Syndrome (Met) (NCT03862950) | University of Alberta | 2019-05-24 |
| Multiple Dose Safety and Efficacy of LKA651 in Patients With Diabetic Macular Edema (NCT03927690) | Novartis Pharmaceuticals | 2019-05-24 |
| Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors (NCT03709680) | Pfizer | 2019-05-24 |
| Sanaria PfSPZ Challenge With Pyrimethamine or Chloroquine Chemoprophylaxis Vaccination (PfSPZ-CVac Approach): A Randomized Double Blind Placebo Controlled Phase I/II Trial to Determine Safety and Protective Efficacy Against Natural Plasmodium Falcipa... (NCT03952650) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-05-23 |
| Micronised Resveratrol as a Treatment for Friedreich Ataxia (NCT03933163) | Murdoch Childrens Research Institute | 2019-05-23 |
| A Study in Recurrent or Metastatic Cervical Cancer Patients With PD-L1 Positive (NCT03808857) | Genor Biopharma Co., Ltd. | 2019-05-23 |
| Estrogen Receptor Beta and Mood (NCT03689543) | National Institute of Mental Health (NIMH) | 2019-05-23 |
| Evaluation of Response to Abiraterone/Prednisone by Race/Ethnicity and Other Factors in Metastatic Hormone Naive Prostate Cancer (NCT03833921) | Martha Mims | 2019-05-23 |
| Trial of Mosunetuzumab (BTCT4465A) as Consolidation Therapy in Participants With Diffuse Large B-Cell Lymphoma Following First-Line Immunochemotherapy and as Monotherapy or in Combination With Polatuzumab Vedotin in Elderly/Unfit Participants With Previously Untreated Diffuse Large B-Cell Lymphoma (NCT03677154) | Hoffmann-La Roche | 2019-05-23 |
| Evaluate the Efficacy and Safety of VVZ-149 Injections for the Treatment of Postoperative Pain Following Bunionectomy (NCT03997812) | Vivozon, Inc. | 2019-05-23 |
| PCI Treatment/Gemcitabine & Chemotherapy vs Chemotherapy Alone in Patients With Inoperable Extrahepatic Bile Duct Cancer (NCT04099888) | PCI Biotech AS | 2019-05-23 |
| Low Dose Multi-OIT for Food Allergy (LoMo) (NCT03799328) | The Hospital for Sick Children | 2019-05-23 |
| A Study to Evaluate the Safety, Tolerability and Efficacy of Multiple Doses of JS002 in Patients With Hyperlipidemia.. (NCT04469673) | Shanghai Junshi Bioscience Co., Ltd. | 2019-05-23 |
| A Clinical Study of Tranilast in the Treatment of Cryopyrin-Associated Periodic Syndrome (CAPS) (NCT03923140) | Peking Union Medical College Hospital | 2019-05-23 |
| Assessment of the Safety and Effect of SAR425899 Versus Placebo for the Treatment of Non-alcoholic Fatty Liver Disease (NCT03437720) | Sanofi | 2019-05-23 |
| Improving Pre-operative Systemic Therapy for Human Epidermal Growth Factor Receptor 2 (HER2) Amplified Breast Cancer (NCT03894007) | Renske Altena | 2019-05-23 |
| An Extension Study of IMR-687 in Adult Patients With Sickle Cell Anemia (NCT04053803) | Imara, Inc. | 2019-05-22 |
| Phase Ib/II Trial of Nal-Irinotecan and Nivolumab as Second-Line Treatment in Patients With Advanced Biliary Tract Cancer (NCT03785873) | University of Michigan Rogel Cancer Center | 2019-05-22 |
| Busulfan, Melphalan, Escalating Carfilzomib Conditioning Auto Stem Cell Transplantation for Multiple Myeloma (MM) (NCT03795597) | Loyola University | 2019-05-22 |
| IPH4102/Lacutamab Alone or in Combination With Chemotherapy in Patients With Advanced T Cell Lymphoma (NCT03902184) | Innate Pharma | 2019-05-22 |
| Evaluation of the Safety and Efficacy Study of RGN-137 Topical Gel for Junctional and Dystrophic Epidermolysis Bullosa (NCT03578029) | Lenus Therapeutics, LLC | 2019-05-22 |
| Infusion of Prostacyclin vs Placebo for 72-hours in Trauma Patients With Haemorrhagic Shock Suffering From Organ Failure (NCT03903939) | Pär Johansson | 2019-05-22 |
| Preemptive Therapy for High Risk Chronic Lymphoid Leukemia Stage A (NCT03766763) | French Innovative Leukemia Organisation | 2019-05-22 |
| KN046 in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma (NCT03927495) | Shanghai Chest Hospital | 2019-05-22 |
| A Study to Assess the Safety and Effectiveness of Pridopidine Compared to Placebo in the Treatment of Levodopa-Induced Dyskinesia in Patients With Parkinson's Disease (NCT03922711) | Prilenia | 2019-05-22 |
| Phase II Study of Treatment for HPV16+ ASC-US, ASC-H and LSIL (NCT03911076) | PapiVax Biotech, Inc. | 2019-05-22 |
| Pembrolizumab-Epacadostat Combination to Treat Muscle-invasive Bladder UrotheLIAl canceR: PECULIAR Study (NCT03832673) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2019-05-22 |
| Induction Paclitaxel Followed by Concurrent Paclitaxel and Radiation Therapy for Cutaneous Angiosarcoma (NCT03921008) | Washington University School of Medicine | 2019-05-21 |
| A Study to Examine the Efficacy and Safety of REGN5069 in Patients With Pain Due to Osteoarthritis of the Knee (NCT03956550) | Regeneron Pharmaceuticals | 2019-05-21 |
| A Study of RVT-1401 in Myasthenia Gravis (MG) Patients (NCT03863080) | Immunovant Sciences GmbH | 2019-05-21 |
| Clinical Trial to Evaluate the Efficacy and Safety of MBA-P01 in Treatment of Lateral Canthal Lines (NCT04143854) | Medy-Tox | 2019-05-21 |
| SCT200 Plus Platinum-based Chemotherapy in Head and Neck Squamous Cell Carcinoma (NCT03874741) | Sinocelltech Ltd. | 2019-05-21 |
| Capecitabine and Temozolomide for Treatment of Recurrent Pituitary Adenomas (NCT03930771) | Weill Medical College of Cornell University | 2019-05-21 |
| Autologous PRP Intra Ovarian Infusion to Restore Ovarian Function in Menopausal Women (NCT03916978) | Genesis Athens Clinic | 2019-05-21 |
| Evaluation of the Efficacy of Stiripentol (Diacomit) as Monotherapy for the Treatment of Primary Hyperoxaluria (NCT03819647) | Biocodex | 2019-05-21 |
| A Proof-of-mechanism Study of Multiple, Oral Doses of Fevipiprant (QAW039) in COPD Patients With Eosinophilia (NCT03810183) | Novartis Pharmaceuticals | 2019-05-21 |
| Mesenchymal Stem Cells Treatment for Decompensated Liver Cirrhosis (NCT03945487) | Beijing 302 Hospital | 2019-05-20 |
| Boost to Brittle Bones - Stem Cell Transplantation for Treatment of Brittle Bones (NCT04623606) | Christian Medical College, Vellore, India | 2019-05-20 |
| Observer-Blinded Dose Escalating, Single Dose to Study Safety and Antimicrobial Efficacy of Gel vs. Placebo (NCT04192513) | DermBiont, Inc. | 2019-05-20 |
| FORWARD Optune and Adjuvant TMZ in Grade II/III Astrocytoma (NCT03906448) | University of Florida | 2019-05-20 |
| Kappa Opioid Receptor Antagonism for the Tx of AUD and Comorbid PTSD (NCT03852628) | Pharmacotherapies for Alcohol and Substance Use Disorders Alliance | 2019-05-20 |
| Anlotinib Hydrochloride Combined With Epirubicin and Ifosfamide for Soft Tissue Sarcoma Patients (NCT03815474) | Liaoning Cancer Hospital & Institute | 2019-05-20 |